| abstract |
A more stable (±) 4-amino-5-chloro-2-ethoxy-N-[[4- (4-fluorobenzyl), which is capable of thoroughly suppressing a decrease in content and withstanding long-term storage. -2-morpholinyl] methyl] benzamide or a salt thereof. (±) 4-amino-5-chloro-2-ethoxy containing substantially no light anhydrous silicic acid, more preferably containing low-substituted hydroxypropylcellulose and / or free of film coating. By preparing a solid preparation containing -N-[[4- (4-fluorobenzyl) -2-morpholinyl] methyl] benzamide or a salt thereof, the decomposition of the active ingredient is more thoroughly suppressed, the storage stability is excellent, and the drug is taken. A solid preparation for oral administration having good properties is obtained. More preferably, they are uncoated tablets. [Selection diagram] None |